Risk factors of atherosclerotic diseasess - Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 6, 2007, Pages 267-277

  Teramoto, Tamio ^a   Sasaki, Jun ^a   Ueshima, Hirotsugu ^a   Egusa, Genshi ^a   Kinoshita, Makoto ^a   Shimamoto, Kazuaki ^a   Daida, Hiroyuki ^a   Biro, Sadatoshi ^a   Hirobe, Kazuhiko ^a   Funahashi, Tohru ^a   Yokote, Koutaro ^a   Yokode, Masayuki ^a  

^a Committee for Epidemiology and Clinical Management Atherosclerosis ^*

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; JAPAN; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; HUMANS; JAPAN; RISK FACTORS;

EID: 41049098468     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E578     Document Type: Article

References (116)

1. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T. Okamura T, Minowa M, and Iimura O: NIPPON DATA80 Research Group: Cigarette Smoking as a Risk Factor for Stroke Death in Japan: NIPPON DATA80. Stroke, 2004; 35:1836-1841
2. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, and Ueshima H; for the NIPPON DATA80 research group: The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis, 2007; 190:216-223
3. Kannel WB: Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens, 2000; 14:83-90
4. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med, 1993; 153:598-615
5. Yano K, Reed DM, and McGee DL: Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am J Epidemiol, 1984; 119:653-666
6. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, and Stander J: Blood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, 1990; 335:765-774
7. Okayama A, Kadowaki T, Okamura T, Hayakawa T, and Ueshima H; The NIPPON DATA80 Research Group: Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens, 2006; 24:459-462
8. Tanizaki Y, Kiyohara Y, and Fujishima M: Journal of Blood Pressure, 2001; 8:737-740 in Japanese
9. Kasaoki F and Kodama K: Risk appraisal chart for coronary heart disease death-Lessons from Nippon DATA. Journal of Clinical and Experiment Medicine (IGAKU NO AYUMI), 2003; 207:463-467
10. Hirobe K: The Lipid, 2002; 13:268-273 in Japanese
11. Hirobe K, Dohi S, Fujioka S, Terai T, and Goto K: The incidence of myocardial infarction at work place (3M Study - 11th report-. Sangouciseigakuzasshi, 2002; 44:490 in Japanese
12. Mabuchi H, Kita T. Matsuzaki M, Matsuzawa, Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, and Itakura H: J-LIT Study Group. Japan Lipid Intevention Trial.: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66:1096-1100
13. Itakura H, et al: The Lipid, 2001; 12:239-247 in Japanese
14. Itakura H: Journal of Clinical and Experimental Medicine (IGAKU NO AYUMI, 2002; Supple: 9-12 in Japanese
15. Doll R and Peto R: Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J, 1976; 2:1525-1536
16. The Pooling Project Research group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chron Dis, 1978; 31:201-306
17. Castelli WP: Epidemiology of coronary heart disease: the Framingham study. Am J Med, 1984; 76:4-12
18. Multiple Risk Factor Intervention Trial Research Group: Relationship betwwen baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med, 1986; 15:254-273
19. Abbott RD, Yin Y, Reed DM, and Yano K: Risk of stroke in male cigarette smokers. N Engl J Med, 1986; 315:717-720
20. Wolf PA, D'Agostino RB, Kannel NW, Bonita R, and Belanger AJ: Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA, 1988; 259:1025-1029
21. Kiyohara Y, Ueda K, and Fujishima M: Smoking and cardiovascular disease in the general population in Japan. J Hypertens, 1990; 8 (Suppl 5):S9-S15
22. Mannami T, Iso H, Baba S, Sasaki S, Okada K, Konishi M, and Tsugane S; Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Group: Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: The JPHC Study Cohort I. Stroke, 2004; 35:1248-1235
23. Baba S, Iso H, Mannami T, Sasaki S, Okada K, and Konishi M; Shoichiro Tsugane; JPHC Study Group; Cigarette smoking and risk of coronary heart disease incidence among middle-aged Japanese men and women; the JPHC Study Cohort I. Eur J Cardiovasc Prev Rehabil, 2006; 13:207-213
24. Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, Koizuml A, Wada Y, Kondo T, Inaba Y, and Tamakoshi A; JACC Study Group: Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Am J Epidemiol, 2005; 161:170-179
25. Sparrow D and Dawber TR: The influence of cigarette smoking on prognosis after a first myocardial infarction: a report from the Framingham study. J Chron Dis, 1978; 31:425-432
26. Salonen JT: Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J, 1980; 43:463-469
27. Sato I, Nishida M, Okita K, Nishijima H, Kojima S, Matsumura N, and Yasuda H: Beneficial effect of stopping smoking on fiiture cardiac events in male smokers with previous myocardial infarction. Circ J, 1992; 56:217-222
28. Ito M and Mishima Y. Risk factor, natural history and prognosis of the patients with arteriosclerosis obliterans. Nippon Geka Gakkai Zasshi, 1996; 97:476-480
29. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, and Tominaga Y. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM. Diabetes Care, 1997; 20:1738-1743
30. Iwamoto T, Sugiyama T, Oyama T, and Tikasaki M: Cerebrovascular diseases in patients with arteriosclerotic aortic aneurysm and arteriosclerosis obliterans studied by carotid ultrasonography and by computed tomography of the brain. Nippon Ronen Igakkai Zassi, 1998; 35:673-679
31. Assmann G and Schulte H: The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J, 1988; 116:1713-1724
32. Stamler J, Vaccaro 0, Neaton JD, and Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care, 1993; 16:434-444
33. Schneider DJ and Sobel BE: Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications. Clin Cardiol, 1997; 20:433-440
34. Haffner SM, Lehto S, Rönemaa T, Pyörälä K, and Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339:229-234
35. Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, and Yashitake T. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama study. Diabetes, 1996; 45 (Suppl 3):S14-S16
36. Kiyohara Y. Diabetic Complications, 2000; 14:80-84 in Japanese
37. National Cholesterol Education Program: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285:2486-2497
38. National Cholesterol Education Program: Adult Treatment Panel III Report (http://www.nhlbi.nih.gov/guidelines/cholesterol/), 2001
39. American Diabetes Association: Management of dyslipidemia in adults with diabetes (position statement). Diabetes Care, 1999; 22:S56-S59
40. Evans JMM, Wang J, and Morris AD: Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ, 2002; 324:939-942
41. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, and Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97:1837-1847
42. Denke MA and Grundy SM: Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med, 1990; 112:780-792
43. Walsh JM and Grady D: Treatment of hyperlipidemia in women. JAMA, 1995; 274:1152-1158
44. Health and Welfare Statistics Association: J Health and Welfare Statistics, 1999; 46:410-411
45. Kodama K, Sasaki H, and Shimizu Y: Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study. Circ J, 1990; 54:414-421
46. Yoshida M, Kira Y, Nakamura Y, Nozaki A, Okayama A, Sugihara H, Kasamatsu T, Hirose K, Kinoshita M, and Ueshima H: Incidence of acute myocardial infarction in Takashima, Shiga, Japan. Circ J, 2005; 69:404-408
47. Tamada T and Iwasaki H: Age at natural menopause in Japanese women. Acta Obst Gynaec Jpn, 1995; 47:947-952
48. Phillips RL, Lilienfeld AM, Diamond EL, and Kagan A: Frequency of coronary heart disease and cerebrovascular accidents in parents and sons of coronary heart disease index cases and controls. Am J Epidemiol, 1974; 100:87-100
49. Snowden CB, McNamara PM, Garrison RJ, Feinleib M, Kannel WB, and Epstein FH: Predicting coronary heart disease in siblings-a multivariate assessment: the Framingham Heart Study. Am J Epidemiol, 1982; 115:217-222
50. Barrett-Connor E and Khaw K: Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation, 1984; 69:1065-1069
51. Colditz, GA, Rimm EB, Giovannucci E, Stampfer MJ, Rosner B, and Willett WC: A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol, 1991; 67:933-938
52. Eaton CB, Bostom AG, Yanek L, Laurino JP, McQuade W, Hume A, and Selhub J: Family history and premature coronary heart disease. J Am Board Fam Pract, 1996; 9:312-318
53. Pohjola-Sintonen S, Rissanen A, Liskola P, and Luomamnäki K: Family history as a risk factor of coronary heart disease in patients under 60 years of age. Eur Heart J, 1998; 19:235-239
54. Silberberg JS, Wlodarczyk J, Fryer J, Robertson R, and Hensley MJ: Risk associated with various definitions of family history of coronary heart disease: the Newcastle Family History Study II. Am J Epidemiol, 1998; 147:1133-1139
55. Li R, Bensen JT, Hutchinson RG, Province MA, Hertz-Picciotto I, Sprafka JM, and Tyroler HA: Family risk score of coronary heart disease (CHD) as a predictor of CHD: the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI family heart study. Genet Epidemiol, 2000; 18:236-250
56. Williams RR, Hunt SC, Heiss G, Province MA, Bensen JT, Higgins M, Chamberlain RM, Ware J, and Hopkins PN: Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study. Am J Cardiol, 2001; 87:129-135
57. Lloyd-Jones DM, Nain BH, D'Agostino RB Sr, Levy D, Murabito JM, Wang TJ, Wilson PW, and O'Donnell CJ: Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offipring. JAMA, 2004; 291:2204-2211
58. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, and Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J, 2002; 66:1087-1095
59. Myers RH, Kiely DK, Cupples LA, and Kannel WB: Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J, 1990; 120:963-969
60. Watkins H and Farrall M: Genetic susceptibility to coronary artery disease: from promise to progress. Nat Rev Genet, 2006; 7:163-173
61. Tarui S: The research committee for primary hyperlipidemia, research on measures for intractable diseases by Ministry for Health, Labor, and Welfare in Japan, Annual report 1986 in Japanese
62. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, and Ueshima H; NIPPON DATA90 Research Group: The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. Atherosclerosis, 2006; 184:143-150
63. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, and Kita T: Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb, 2005; 12:98-106
64. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, and Tall AR: Increased highdensity lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med, 1990; 323:1234-1238
65. Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y, et al: Genetic cholesteryl ester transfer protein deficiency caused by two prevalent high density lipoprotein cholesterol. J Clin Invest, 1994; 94:1872-1882
66. Hirano K, Yamashita S, Nakajima N, Arai T, Miruyama T, Yoshida Y, Ishigaini M, Sakai N, Kameda-Takemura K, and Matsuzawa Y: Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol, 1997; 17:1053-1059
67. Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M, Sagehashi Y, Kujiraoka T, Tanaka K, Hattori H, Sakai N, Nakajima N, Egashira T, and Matsuzawa Y: Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb, 2004; 11:110-121
68. Satoh H, Nishino T, Tomita K, and Tsutsui H: Fasting triglyceride is a significant risk factor for coronary artery disease in middleaged Japanese men. Circ J, 2006; 70:227-231
69. Kukita H and Hiwada K: Epidemiology of hypertriglyceridemia in relation to atherosclerotic cardiovascular diseases in Japanese male patients. Ther Res, 1993; 14:551-558
70. Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, and Komachi Y: Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol, 2001; 153:490-499
71. Fager G, Wiklund O, Olofsson SO, Wilhelmsen L, and Bondjers G: Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis, 1981; 1:273-279
72. Castelli WP: The triglyceride issue: a view from Framingham. Am Heart J, 1986; 112:432-437
73. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, and Claude JR: Is the level of serum triglyceride a significant predictor of coronary death in normocholesterolemic subjects? The Paris Prospective Study. Am J Epidemiol, 1986; 124:624-632
74. Austin MA: Plasma triglyceride and coronary heart disease. Arterioscler Thromb, 1991; 11:2-14
75. Austin MA, Hokanson JE, and Edwards KL: Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol, 1998; 81:7B-12B
76. Jeppesen J, Hein HO, Suadicani P, and Gyntelberg F: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation, 1998; 97:1029-1036
77. Hulley SB, Rosenman RH, Bawol RD, and Brand RJ: Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med, 1980; 302:1383-1389
78. Castelli WP: Lipids, risk factors and ischaernic heart disease. Atherosclerosis, 1996; 124 (Suppl):S1-S9
79. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, and Becker AE: Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 2001; 103:1955-1960
80. Meisinger C, Baumert J, Khuseyinova N, Loewel H, and Koenig W: Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population. Circulation, 2005; 112:651-657
81. Howard GC and Pizzo SV: Lipoprotein(a) and its role in atherothrombotic disease. Lab Invest, 1993; 69:373-86
82. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, and Levy RI: Lipoprotein(a) levels and risk of coronary heart disease in men: the lipid Research Clinics Coronary Primary Prevention Trial. JAMA, 1994; 271:999-1003
83. Maher VM and Brown BG: Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol, 1995; 6:229-235
84. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ, and Castelli W: Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA, 1996; 276:544-548
85. Stein JH and Rosenson RS: Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med, 1997; 157:1170-1176
86. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, and Lawn RM: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature, 1987; 330:132-137
87. Hajjar KA and Nachman RL: The role of lipoprotein(a) in atherogenesis and thrombosis. Annu Rev Med, 1996; 47:423-442
88. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, and Berger PB: Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med, 2005; 353:46-57
89. Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, and Juhan-Vague I: Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost, 1998; 80:749-756
90. Karpe F: Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med, 1999; 246:341-355
91. Austin MA, Breslow JI, Hennekens CH, Buring JE, Willett WC, and Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA, 1988; 260:1917-1921
92. Krauss RM: Low-density lipoprotein subclass and risk of coronary disease. Curr Opin Lipidol, 1991; 4:248-252
93. de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, and Stalenhoef AF: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb, 1991; 11:298-306
94. Galeano NF, Al-Haideri M, Keyserman F, Rumsey SC, and Deckelbaum RJ: Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res, 1998; 39:1263-1273
95. Reaven GM, Chen YD, Jeppesen J, Maheux P, and Krauss RM: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest, 1993; 92:141-146
96. Austin MA and Edwards KL: Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulindependent diabetes. Curr Opin Lipidol, 1996; 7:167-171
97. Boushey CJ, Beresford SA, Omenn GS, and Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA, 1995; 274:1049-1057
98. Gerhard GT and Duell PB: Homocysteine and atherosclerosis. Curr Opin Lipidoll 1999; 10:417-428
99. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, and Hennekens CH: A prospective study of plasma homocyst(e) ine and risk of myocardial infarction in US physicians. JAMA, 1992; 268:877-881
100. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993; 362:801-809
101. Alexander RW: Inflammation and coronary artery disease. N Engl J Med, 1994; 331:468-469
102. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, and Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997; 336:973-979
103. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, and Kuller LH: Relationship of Creactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol, 1997; 17:1121-1127
104. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, and Pepys MB: C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation, 1999; 99:237-242
105. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, and Maseri A: The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med, 1994; 331:417-424
106. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 2003; 107:363-369
107. Libby P and Ridker PM: Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med, 2004; 116 (Suppl 6A):9S-16S
108. Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, and Lusis AJ: Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation, 1997; 96:2914-2919
109. Fuster V: Lewis A. Conner Memorial Lecture: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation, 1994; 90:2126-2146
110. Kannel WB, Wolf PA, Castelli WP, and D'Agostino RB: Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA, 1987; 258:1183-1186
111. Thompson SG, Kienast J, Pyke SD, Haverkate F, and van de Loo JC: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med, 1995; 332:635-641
112. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, and Chambless LE: Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 1997; 96:1102-1108
113. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, and Savage P: The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol, 1999; 19:1776-1783
114. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, and Juhan-Vague: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes, 1997; 46:860-867
115. Juhan-Vague I and Alessi MC: PAI-1, obesity, insulin resistaticc and risk of cardiovascular events. Thromb Haemost, 1997; 78:656-660
116. Kathiresan S, Gona P, Larson MG, Vita JA, Mitchell GF, Tofler GH, Levy D, Newton-Cheh C, Wang TJ, Benjamin EJ, and Vasan RS: Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation, 2006; 113:938-945